In response to a proposal submitted by Intas Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs ...

Glenmark Pharmaceuticals seeks licensing deal for ISB 2001 drug candidate, plans growth with semaglutide in India.

A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

In an effort to promote the use of genuine products, Novo Nordisk is offering a one-time first-month offer for Wegovy at $199 ...

A doctor has issued a stark 15-year warning to Ozempic users after the weight loss drug's brutal aftermath was revealed in a simulation ...

"Social media will turn everyone into brain-dead zombies with a medieval-level understanding of the real world." ...

An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

FAT JABS have taken the nation’s waistline by storm – trimming inches and helping thousands shed weight, and fast. But it ...

Weight-loss drugs cannot be a short-term solution and GPs will need to engage with obesity management as the medicines are ...

Mumbai-based Supriya Lifescience is betting on a steady growth trajectory over the next few years, with Managing Director Saloni Wagh guiding for over 20% revenue growth annually. “That’s the guidance ...